SG11202008791UA - Agent for prevention and/or treatment of pseudomonas aeruginosa infection - Google Patents

Agent for prevention and/or treatment of pseudomonas aeruginosa infection

Info

Publication number
SG11202008791UA
SG11202008791UA SG11202008791UA SG11202008791UA SG11202008791UA SG 11202008791U A SG11202008791U A SG 11202008791UA SG 11202008791U A SG11202008791U A SG 11202008791UA SG 11202008791U A SG11202008791U A SG 11202008791UA SG 11202008791U A SG11202008791U A SG 11202008791UA
Authority
SG
Singapore
Prior art keywords
prevention
agent
treatment
pseudomonas aeruginosa
aeruginosa infection
Prior art date
Application number
SG11202008791UA
Other languages
English (en)
Inventor
Susumu Kawaguchi
Miho Kato
Original Assignee
Nutri Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutri Co Ltd filed Critical Nutri Co Ltd
Publication of SG11202008791UA publication Critical patent/SG11202008791UA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11202008791UA 2018-04-19 2019-04-17 Agent for prevention and/or treatment of pseudomonas aeruginosa infection SG11202008791UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018080756 2018-04-19
PCT/JP2019/016441 WO2019203260A1 (fr) 2018-04-19 2019-04-17 Agent pour la prévention et/ou le traitement d'une infection par pseudomonas aeruginosa

Publications (1)

Publication Number Publication Date
SG11202008791UA true SG11202008791UA (en) 2020-11-27

Family

ID=68238941

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202008791UA SG11202008791UA (en) 2018-04-19 2019-04-17 Agent for prevention and/or treatment of pseudomonas aeruginosa infection

Country Status (9)

Country Link
US (1) US12053496B2 (fr)
EP (1) EP3782631A4 (fr)
JP (1) JP7296369B2 (fr)
KR (1) KR102681178B1 (fr)
CN (1) CN111867607A (fr)
AU (1) AU2019257028A1 (fr)
CA (1) CA3096433A1 (fr)
SG (1) SG11202008791UA (fr)
WO (1) WO2019203260A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3229107A1 (fr) * 2021-08-27 2023-03-02 Nutri Co., Ltd. Agent pour la prevention et/ou le traitement d'une infection par porphyromonas gingivalis
CN115090225A (zh) * 2022-05-12 2022-09-23 重庆中科力泰高分子材料股份有限公司 一种新型高效除醛透明凝胶及其制备方法
KR20240033466A (ko) 2022-09-05 2024-03-12 국립부경대학교 산학협력단 도시 대기환경 분석 시스템 및 이를 이용한 도시 대기환경 분석 방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08283166A (ja) * 1995-04-12 1996-10-29 Nichinichi Seiyaku Kk 感染防御剤
JP2002179580A (ja) * 2000-12-13 2002-06-26 Zenwa Gu プロポリス抽出物、ロイヤルゼリー、及びエンテロコッカス・フェカリス死菌体を含んでなる医薬
SG93936A1 (en) * 2001-05-21 2003-01-21 Combi Co Infection-preventing composition, and food or drink containing the same
JP2003261453A (ja) 2002-03-11 2003-09-16 Nippon Berumu Kk Ｅ．フェカリスからなる抗腫瘍剤及び放射線防護剤
US20090098520A1 (en) * 2007-10-13 2009-04-16 Aaron Wilson Dressage flexion and extension training device and method
JP5555184B2 (ja) * 2008-02-06 2014-07-23 ユニバーシティ・オブ・イースト・アングリア 嚥下を支援するための組成物および方法
ES2674328T3 (es) 2011-05-06 2018-06-28 Belano Medical Ag Nuevas bacterias de ácido láctico y composiciones que las contienen
CN103751223A (zh) * 2011-10-17 2014-04-30 陈双露 抑制感染组合物及含有该组合物的饮食品
EP3352585A1 (fr) * 2015-09-21 2018-08-01 Institut National de la Recherche Agronomique (INRA) Institut national de la recherche agronomique (inra) et institut supérieur des sciences agronomiques, agroalimentaires, horticoles et du paysage
JP2018080756A (ja) 2016-11-16 2018-05-24 日本精工株式会社 シール付き転がり軸受

Also Published As

Publication number Publication date
US20200405784A1 (en) 2020-12-31
JP7296369B2 (ja) 2023-06-22
US12053496B2 (en) 2024-08-06
JPWO2019203260A1 (ja) 2021-04-30
EP3782631A1 (fr) 2021-02-24
WO2019203260A1 (fr) 2019-10-24
EP3782631A4 (fr) 2022-01-05
AU2019257028A1 (en) 2020-10-01
KR20210002461A (ko) 2021-01-08
KR102681178B1 (ko) 2024-07-04
CN111867607A (zh) 2020-10-30
CA3096433A1 (fr) 2019-10-24

Similar Documents

Publication Publication Date Title
EP3777888A4 (fr) Composition pharmaceutique pour le traitement et/ou la prévention du cancer
ZA201908165B (en) Compounds for the prevention and treatment of diseases and the use thereof
EP3639833A4 (fr) Agent pour la prévention ou le traitement de maladies liées à la graisse et/ou de l'inflammation
SG11202008791UA (en) Agent for prevention and/or treatment of pseudomonas aeruginosa infection
IL270976A (en) IL-8 inhibitors for use in the treatment and/or prevention of secondary bacterial infection
ZA202000558B (en) Prevention and/or treatment of neurodegenerative disease
EP4225923A4 (fr) Compositions et méthodes pour prévenir et/ou traiter la covid-19
HUE058250T2 (hu) Gyógyszer rhinovírus-fertõzés megelõzésére vagy kezelésére
SG11201809811VA (en) Compositions and methods for treatment of inflammation or infection of the eye
EP3937634A4 (fr) Matériaux et procédés pour le traitement et la prévention améliorés de biofilms
GB201704688D0 (en) Calcicum based clinical material with antimicrobial properties and method of forming for prevention or treatment of infection
IL282904A (en) Therapeutic microbiota for the treatment and/or prevention of dysbiosis
EP3661502A4 (fr) Composés pour la prévention et le traitement de troubles médicaux et leurs utilisations
EP3610879A4 (fr) Composition de traitement et/ou de prévention de la maladie d'alzheimer
EP3789019A4 (fr) Composition pour la prévention ou le traitement d'une infection cutanée
EP3856747C0 (fr) Pyridoindoles substitués pour le traitement et la prophylaxie d'une infection bactérienne
EP3710015C0 (fr) Utilisation d'agents srsf3 pour le traitement et/ou la prévention d'affections neurologiques, du cancer, d'infections bactériennes ou d'infections virales
ZA201808182B (en) Composition comprising at least one enzyme and at least one microbicidal molecule for the prevention or treatment of post-implant infections
EP3525771A4 (fr) Prévention et/ou traitement d'une insuffisance rénale aiguë induite par des agents de contraste
EP4041275A4 (fr) Traitement et prévention de lésions rénales induites par la néphrotoxine
EP3811958A4 (fr) Composition permettant de prévenir et/ou de traiter les hémorroïdes
HUE062180T2 (hu) Palonosetron szemcsepp a hányinger és a hányás kezelésére vagy megelõzésére
PT3829535T (pt) Composições para prevenção e tratamento de afeções cutâneas
EP3967300C0 (fr) Composition pour la prévention et le traitement d'infections et/ou d'inflammations
GB202210704D0 (en) Biofilm prevention and treatment